Skip to content

The clinical efficacy and mechanism exploration of auricular acupressure in MHD patients with sleep disorder

The clinical efficacy and mechanism exploration of auricular acupressure in MHD patients with sleep disorder

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085503
Enrollment
Unknown
Registered
2024-06-11
Start date
2024-06-14
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders on maintenance hemodialysis

Interventions

Experimental Group:Auricular acupressure combined with basic nursing treatment
Control group:Basic nursing treatment

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients with end-stage renal disease who have been on regular hemodialysis for at least 3 months and are 18 years of age or older; (2) The patient meets the TCM diagnostic criteria for sleep disorder; (3) Patients with PSQl>7; (4) Patients with relatively stable condition and no serious complications of heart, brain or lung during the first 3 months of enrollment; (5) The patient is conscious and can be combined with auricular acupressure.

Exclusion criteria

Exclusion criteria: (1) External ear skin damage, inflammation, deformity or allergy to auricle plastel; (2) Severe hearing and language disorders, unable to answer correcth; (3) History of intestinal disease or other gastrointestinal diseases within three months; (4) Use of microecological preparations, antibiotics or traditional Chinese medicine preparations in the past two weeks.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
GAD-7 for anxiety level;PHQ-9 for depression level;Traditional Chinese medicine symptom score;Interleukin-6;Interleukin-10;Interleukin-18;Interleukin-1ß;C-reactive protein;Tumor necrosis factor-a;Gut microbiota;Adverse events;

Countries

China

Contacts

Public ContactXueling Ma

Beijing University of Chinese Medicine

maxl@bucm.edu.cn+86 152 0130 9664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026